Member? Log in...

Join or renew today

Latest Reports/Studies

GAO report: FDA has begun to enhance postmarket drug safety, but additional actions are needed

In its evaluation of FDA efforts to enhance postmarket drug safety, the Government Accountability Office finds the FDA has begun to enhance postmarket drug safety, but additional actions are needed. In particular, the GAO pushes the FDA to grant greater independence to the folks responsible for monitoring and enforcing postmarket drug safety.